Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

History of Medicine

About   |  Collections   |  Exhibitions   |  Research Tools   |  Copyright   |  Get Involved   |  Visit   |  Contact

Smallpox: A Great and Terrible Scourge banner
Smallpox: A Great and Terrible Scourge written in white lettering with a black border Public Health Service Historian History of Medicine Division National Library of Medicine National Institutes of Health The Threat written in red letters. Variolation written in red letters. Vaccination written in red letters. Resistance to Vaccination written in red letters. The 20th Century Threat written in red letters. Campaign to Eradicate written in red letters. Obstacles and Struggle written in red letters. Success written in red letters.

Success

FIFTY-FIFTH WORLD HEALTH ASSEMBLY
WHA55.15
Agenda item 13.16
18 May 2002

Smallpox eradication: destruction of Variola virus stocks

The Fifty-fifth World Health Assembly, Recalling resolution WHA52.10 on smallpox eradication; Having considered the report on smallpox eradication;1 Noting that the research programme will not be completed by the end of 2002,

  1. DECIDES to authorize the further, temporary, retention of the existing stocks of live Variola virus at the current locations specified in resolution WHA52.10, for the purpose of enabling further international research, on the understanding that steps should be taken to ensure that all approved research would remain outcome-oriented and time-limited and periodically reviewed and a proposed new date for destruction should be set when the research accomplishments and outcomes allow consensus to be reached on the timing of destruction of Variola virus stocks;
  2. REQUESTS the Director-General:
    1. to continue the work of the Advisory Committee on Variola Virus Research with respect to the research involving Variola virus stocks and to ensure that the research programme is conducted in an open and transparent manner;
    2. to ensure that regular biosafety inspection of the storage and research facilities is continued in order to confirm the strict containment of existing stocks and to ensure a safe research environment for work with Variola virus;
    3. to ensure that research results and the benefits of this research are made available to all Member States;
    4. to report annually the progress in the research programme and relevant issues to the World Health Assembly, through the Executive Board.

Ninth plenary meeting, 18 May 2002
A55/VR/9
1 Document A55/21.

Last Reviewed: March 5, 2024